Related Experiment Video
Updated: Sep 27, 2025

Basics of Multivariate Analysis in Neuroimaging Data
Published on: July 24, 2010
Optimizing Graphical Procedures for Multiplicity Control in a Confirmatory Clinical Trial via Deep Learning
Tianyu Zhan1, Alan Hartford2, Jian Kang3
1Data and Statistical Sciences, AbbVie Inc., North Chicago, IL.
Abstract:
In confirmatory clinical trials, it has been proposed to use a simple iterative graphical approach to construct and perform intersection hypotheses tests with a weighted Bonferroni-type procedure to control Type I errors in the strong sense. Given Phase II study results or other prior knowledge, it is usually of main interest to find the optimal graph that maximizes a certain objective function in a future Phase III study. In this article, we evaluate the performance of two existing derivative-free constrained methods, and further propose a deep learning enhanced optimization framework. Our method numerically approximates the objective function via feedforward neural networks (FNNs) and then performs optimization with available gradient information. It can be constrained so that some features of the testing procedure are held fixed while optimizing over other features. Simulation studies show that our FNN-based approach has a better balance between robustness and time efficiency than some existing derivative-free constrained optimization algorithms. Compared to the traditional stochastic search method, our optimizer has moderate multiplicity adjusted power gain when the number of hypotheses is relatively large. We further apply it to a case study to illustrate how to optimize a multiple testing procedure with respect to a specific study objective.
More Related Videos
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018